Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

ECDC advocates for execution of respiratory syncytial virus (RSV) immunization programs including maternal vaccines to protect infants from severe hospitalization.

Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...

In almost two-thirds of instances, hospitals experiencing pediatric bed shortages were situated close to others with ...

Although the CDC reports that the fall flu season in the US is currently mild, measles and hand-foot-mouth disease (HFMD) are ...

Few artists embody versatility like Mandy Moore, whose career spans music, film, and television. Moore first rose to fame as ...

Pneumonia can range from mild to severe; it can even be life-threatening in some cases. It can affect one or both lungs. Photograph used for representational purposes only | Photo Credit: ...

In almost two-thirds of instances, hospitals experiencing pediatric bed shortages were situated close to others with ...

In the heart of Halifax, the Canadian Center for Vaccinology has quietly become one of Canada’s most influential voices in ...

Federal messaging surrounding vaccines and misinformation on social media are two main reasons why pregnant patients are ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...